Pulmonary Hypertension and Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity-Is There a Link?

JAMA Ophthalmol. 2022 Nov 1;140(11):1094-1095. doi: 10.1001/jamaophthalmol.2022.3824.
No abstract available

Publication types

  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Bevacizumab / therapeutic use
  • Endothelial Growth Factors / therapeutic use
  • Humans
  • Hypertension, Pulmonary* / drug therapy
  • Infant, Newborn
  • Intravitreal Injections
  • Retinopathy of Prematurity*

Substances

  • Endothelial Growth Factors
  • Angiogenesis Inhibitors
  • Bevacizumab